Transient Hyperglycemia in a Patient With Type 2 Diabetes After COVID-19 Messenger RNA Vaccination: A Case Report
Aniebietabasi Okon-Umoren • Sean Yaphe • Andrea Smith • Karla D. Passalacqua • Katarzyna Budzynska, Published: July 06, 2024, DOI: 10.7759/cureus.63983 Abstract The development of new vaccines against the SARS-CoV-2 virus in response to the COVID-19 pandemic represents a milestone in the history of public health. However, due to the rapid development and short duration of these new vaccines, the full spectrum of side effects […]